Search Results

There are 2975360 results for: content related to: Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Article first published online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. You have full text access to this OnlineOpen article
    A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial

    Hepatology

    Volume 47, Issue 3, March 2008, Pages: 844–853, Chiun Hsu, Chao A. Hsiung, Ih-Jen Su, Wei-Shou Hwang, Ming-Chung Wang, Sheng-Fung Lin, Tseng-Hsi Lin, Hui-Hua Hsiao, Ji-Hsiung Young, Ming-Chih Chang, Yu-Min Liao, Chi-Cheng Li, Hung-Bo Wu, Hwei-Fang Tien, Tsu-Yi Chao, Tsang-Wu Liu, Ann-Lii Cheng and Pei-Jer Chen

    Article first published online : 27 DEC 2007, DOI: 10.1002/hep.22106

  3. You have full text access to this OnlineOpen article
    Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection

    Alimentary Pharmacology & Therapeutics

    Volume 24, Issue 7, October 2006, Pages: 1003–1016, H. E. KOHRT, D. L. OUYANG and E. B. KEEFFE

    Article first published online : 12 SEP 2006, DOI: 10.1111/j.1365-2036.2006.03081.x

  4. You have free access to this content
    Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and management

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 5, May 2010, Pages: 864–871, John S Lubel and Peter W Angus

    Article first published online : 28 APR 2010, DOI: 10.1111/j.1440-1746.2010.06243.x

  5. You have full text access to this OnlineOpen article
    Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma

    Cancer

    Volume 106, Issue 6, 15 March 2006, Pages: 1320–1325, Yu-Hong Li, Yi-Fu He, Wen-Qi Jiang, Fen-Hua Wang, Xu-Bin Lin, Li Zhang, Zhong-Jun Xia, Xiao-Fei Sun, Hui-Qiang Huang, Tong-Yu Lin, You-Jian He and Zhong-Zhen Guan

    Article first published online : 8 FEB 2006, DOI: 10.1002/cncr.21701

  6. Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis

    Journal of Viral Hepatitis

    Volume 15, Issue 2, February 2008, Pages: 89–102, L. H. Katz, A. Fraser, A. Gafter-Gvili, L. Leibovici and R. Tur-Kaspa

    Article first published online : 24 SEP 2007, DOI: 10.1111/j.1365-2893.2007.00902.x

  7. You have full text access to this OnlineOpen article
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  8. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies

    Journal of Viral Hepatitis

    Volume 11, Issue 2, March 2004, Pages: 141–147, R. Idilman, M. Arat, E. Soydan, M. Törüner, İ. Soykan, H. Akbulut, Ö. Arslan, M. Özcan, A. R. Türkyilmaz, M. Bozdayı, S. Karayalçın, D. H. Van Thiel, A. Özden, M. Beksaç and H. Akan

    Article first published online : 20 FEB 2004, DOI: 10.1046/j.1365-2893.2003.00479.x

  9. You have full text access to this OnlineOpen article
    Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy

    Hepatology

    Volume 43, Issue 2, February 2006, Pages: 209–220, Winnie Yeo and Philip J. Johnson

    Article first published online : 26 JAN 2006, DOI: 10.1002/hep.21051

  10. Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis

    Liver International

    Volume 28, Issue 1, January 2008, Pages: 28–38, Lenna A. Martyak, Ehsan Taqavi and Sammy Saab

    Article first published online : 1 NOV 2007, DOI: 10.1111/j.1478-3231.2007.01618.x

  11. Hepatitis B virus reactivation associated with anti-neoplastic therapy

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 1, January 2013, Pages: 31–37, Winnie Yeo and Henry LY Chan

    Article first published online : 19 DEC 2012, DOI: 10.1111/j.1440-1746.2012.07280.x

  12. Hepatitis B reactivation in allogeneic hemopoietic stem cell transplantation setting: A pediatric experience

    Pediatric Transplantation

    Volume 13, Issue 7, November 2009, Pages: 923–926, M. Faraci, B. Cappelli, E. Lanino, G. Morreale, F. Fioredda, C. L. Giudice and R. Giacchino

    Article first published online : 19 NOV 2008, DOI: 10.1111/j.1399-3046.2008.01080.x

  13. Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration

    Liver International

    Volume 24, Issue 6, December 2004, Pages: 540–546, M. S. Dai, P. F. Wu, R. Y. Shyu, J. J. Lu and T. Y. Chao

    Article first published online : 26 NOV 2004, DOI: 10.1111/j.1478-3231.2004.0964.x

  14. You have full text access to this OnlineOpen article
    Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy—A prospective case series

    American Journal of Hematology

    Volume 80, Issue 3, November 2005, Pages: 197–203, Themistoklis Vassiliadis, Vassilia Garipidou, Konstantinos Tziomalos, Vassilios Perifanis, Olga Giouleme and Sofia Vakalopoulou

    Article first published online : 24 OCT 2005, DOI: 10.1002/ajh.20471

  15. You have full text access to this OnlineOpen article
    Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature

    Journal of Internal Medicine

    Volume 253, Issue 5, May 2003, Pages: 544–552, Z. Ben-Ari, 1 E. Mor and 2 R. Tur-Kaspa 1

    Article first published online : 17 APR 2003, DOI: 10.1046/j.1365-2796.2003.01134.x

  16. Management of viral hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 17, Issue s1, February 2002, Pages: S125–S145, CHUTIMA PRAMOOLSINSUP

    Article first published online : 8 MAY 2002, DOI: 10.1046/j.1440-1746.17.s1.3.x

  17. Role of lamivudine with transarterial chemoembolization in the survival of patients with hepatocellular carcinoma

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 6, June 2014, Pages: 1273–1278, Xiaojing Xu, Peixin Huang, Hui Tian, Yi Chen, Ningling Ge, Wengquing Tang, Biwei Yang and Jinglin Xia

    Article first published online : 15 MAY 2014, DOI: 10.1111/jgh.12554

  18. Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy

    Journal of Medical Virology

    Volume 59, Issue 3, November 1999, Pages: 263–269, Winnie Yeo, Joyce L. Steinberg, John S. Tam, Paul K.S. Chan, Nancy W.Y. Leung, Kwok C. Lam, Tony S.K. Mok and Philip J. Johnson

    Article first published online : 27 SEP 1999, DOI: 10.1002/(SICI)1096-9071(199911)59:3<263::AID-JMV1>3.0.CO;2-X

  19. You have full text access to this OnlineOpen article
    Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: A decision analysis model

    Hepatology

    Volume 46, Issue 4, October 2007, Pages: 1049–1056, Sammy Saab, Mamie H. Dong, Tom A. Joseph and Myron J. Tong

    Article first published online : 6 AUG 2007, DOI: 10.1002/hep.21783

  20. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease

    Liver International

    Volume 33, Issue 8, September 2013, Pages: 1203–1210, Fei W. Chen, Luke Coyle, Brett E. Jones and Venessa Pattullo

    Article first published online : 24 MAR 2013, DOI: 10.1111/liv.12154